Mr. Aguilera has been involved in the securities industry for over 26 years as an advisor to high net worth individual investors.
Mr. Aguilera is the Founder of BioRevolution Capital Management, LLC. He acted as an advisor from 2007 to 2013 to Global Advisory Services Group, LLC (based in New York City) in the biotech field, and specializes in developing potential strategic partnerships with international pharmaceutical companies. Mr. Aguilera was a Senior Financial Consultant at Great Eastern Securities, Inc. and Sandgrain Securities, Inc. from June 2002 to January 2007. From April of 1999 until joining Sandgrain, Mr. Aguilera was a Senior Vice President at Josephthal & Co., Inc., which was subsequently acquired by Fahnestock & Co., Inc. Mr. Aguilera was at DH Blair & Co. Inc. from 1984 until DH Blair & Co. was acquired by Barington Capital Group, L.P., and remained at Barington Capital Group, L.P. until April of 1999.
In each of these positions Mr. Aguilera’s experience was in the biotechnology sector. Through this experience he has developed a specialization in biotechnology companies (biotechnology companies having a market capitalization of up to half a billion dollars). This experience led to a twelve month financial consulting position with Vion Pharmaceuticals, a cancer research company, beginning in December of 1998.
Mr. Aguilera is a graduate of Adelphi University, where he received a B.S. in Finance in May 1984.
I would like to put a quote here from one of the portfolio company CEO or founders that acknowledges the benefits of working with Mr. Chen and Delos Capital.
President, Company Name